IQV vs MEDP: stock comparison and AI forecast
Iqvia Holdings Inc. (IQV) and Medpace Holdings, Inc. (MEDP) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
IQV Iqvia Holdings Inc.
- Market Cap
- $43.94B
- P/E Ratio
- 31.5x
- Size
- large-cap
- AI Forecast
MEDP Medpace Holdings, Inc.
- Market Cap
- $18.95B
- P/E Ratio
- 37.6x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- IQV is 2.3 times larger than MEDP by market capitalization ($43.94B against $18.95B).
- IQV trades at 31.5 times trailing earnings, MEDP at 37.6 times.
- MEDP turns 18.2% of its revenue into net income, against 8.1% for IQV.
- IQV carries 3.56 times debt per unit of equity, against 2.94 times for MEDP.
- Both companies share the SEC industry classification Services-Commercial Physical & Biological Research.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | IQV | MEDP |
|---|---|---|
| Market Cap | $43.94B | $18.95B |
| P/E Ratio | 31.48x | 37.60x |
| P/B Ratio | 6.60x | 32.40x |
| EPS | $8.21 | $18.02 |
| Book Value/Share | $39.18 | $20.91 |
| Revenue/Share | $101.83 | $101.47 |
| FCF/Share | $12.23 | $23.87 |
Profitability & Margins
| Metric | IQV | MEDP |
|---|---|---|
| ROE | 20.9% | 88.5% |
| ROA | 4.6% | 22.5% |
| ROIC | 9.8% | 75.3% |
| Gross Margin | 33.1% | – |
| Operating Margin | 12.8% | 21.4% |
| Net Margin | 8.1% | 18.2% |
| EBT Margin | 9.6% | 22.1% |
| Tax Rate | 15.4% | 17.4% |
Financial Health
| Metric | IQV | MEDP |
|---|---|---|
| Current Ratio | 0.83x | 0.83x |
| D/E Ratio | 3.56x | 2.94x |
| Financial Leverage | 4.58x | 3.94x |
| Interest Coverage | 2.8x | 733.2x |
| Working Capital | -$1.33B | -$251M |
Cash Flow
| Metric | IQV | MEDP |
|---|---|---|
| Operating Cash Flow | $2.74B | $723M |
| Free Cash Flow | $2.08B | $668M |
| Capital Spending | -$657M | -$55M |
| OCF Growth YoY | -2.4% | 1.7% |
| FCF Growth YoY | -6.0% | -1.4% |
| FCF/Sales | 12.0% | 23.5% |
| CapEx/Sales | 3.8% | 1.9% |
Operational Efficiency
| Metric | IQV | MEDP |
|---|---|---|
| Asset Turnover | 0.57x | 1.23x |
| Receivables Turnover | 5.3x | 6.8x |
| Fixed Assets Turnover | 32.4x | 16.2x |
| Days Sales Outstanding | 69 days | 54 days |
| Payables Period | 116 days | – |
Income Statement
| Metric | IQV | MEDP |
|---|---|---|
| Total Revenue | $17.31B | $2.84B |
| Operating Income | $2.22B | $607M |
| Net Income | $1.39B | $518M |
| SG&A Expense | $2.11B | $193M |
| Cost of Goods Sold | $11.59B | – |
Dividend & Shareholder Information
| Metric | IQV | MEDP |
|---|---|---|
| Shares Outstanding | 170M | 28M |
| Net Income Growth | 8.7% | 19.6% |
| EPS Growth | 12.8% | 26.0% |
IQV vs MEDP: stock comparison and AI forecast
Which is bigger, IQV or MEDP?
IQV is 2.3 times larger than MEDP by market capitalization ($43.94B against $18.95B).
Which is cheaper on earnings, IQV or MEDP?
IQV trades at 31.5 times trailing earnings, MEDP at 37.6 times.
Which one does Intratio's AI model rank higher, IQV or MEDP?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.